A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...

Dr. Eddie Méndez was a physician-scientist and cherished colleague at Fred Hutch who died of cancer in 2018 at age 45. An expert in head and neck cancers, Méndez was known for being passionate about ...

I began working at Fred Hutch at the start of 2025, and I split my time between general oncology patients and the palliative care team. At the South Lake Union clinics, I see a wide variety of ...

Colorectal cancer can be treated using immunotherapy approaches that use the immune cells to target cancer cells and induce the killing of those cancer cells. Some colorectal cancer types have been ...

Many cells comprise the tumor microenvironment, but endothelial cells are particularly crucial. They line blood vessels, regulating blood flow and inflammation, and their cell junctions are the ...

Save the Date: the Sloan Precision Oncology Institute is hosting a Theranostics Symposium on February 28, 2025. This symposium will feature a panel of local and national leaders in the field who will ...

At Fred Hutch, we believe that quality of life is essential to building a rewarding career — and achieving our shared mission of advancing breakthroughs and saving lives. It starts with a supportive ...

Are you ready to start a new Obliteride team — or bring your team back this year? Join us on Fred Hutch's Seattle campus for our Team Captain Kickoff! You’ll hear from fellow team captains about how ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

As we near the five-year mark since the start of the COVID-19 pandemic, the healthcare community is still wrestling with the psychological fallout of being on the frontlines of a global crisis. The ...